Total Payments
$10,574
2024 Payments
$841.41
Companies
27
Transactions
348
Medicare Patients
592
Medicare Billing
$61,745
Payment Breakdown by Category
Food & Beverage$6,235 (59.0%)
Other$3,000 (28.4%)
Consulting$1,339 (12.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,235 | 344 | 59.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $3,000 | 2 | 28.4% |
| Consulting Fee | $1,339 | 2 | 12.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| RedHill Biopharma Inc. | $5,046 | 36 | $0 (2023) |
| ABBVIE INC. | $1,988 | 108 | $0 (2024) |
| Gilead Sciences, Inc. | $1,175 | 65 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $325.91 | 25 | $0 (2024) |
| Celgene Corporation | $274.53 | 17 | $0 (2023) |
| QOL Medical, LLC | $234.51 | 16 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $201.15 | 9 | $0 (2021) |
| Synergy Pharmaceuticals Inc | $126.89 | 11 | $0 (2018) |
| Janssen Biotech, Inc. | $124.16 | 7 | $0 (2023) |
| IRONWOOD PHARMACEUTICALS, INC | $112.78 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $841.41 | 45 | ABBVIE INC. ($299.04) |
| 2023 | $913.96 | 46 | AbbVie Inc. ($238.83) |
| 2022 | $844.02 | 39 | ABBVIE INC. ($299.49) |
| 2021 | $2,608 | 71 | RedHill Biopharma Inc. ($1,733) |
| 2020 | $3,821 | 44 | RedHill Biopharma Inc. ($3,186) |
| 2019 | $771.87 | 54 | AbbVie, Inc. ($294.48) |
| 2018 | $753.24 | 48 | AbbVie, Inc. ($358.43) |
| 2017 | $20.31 | 1 | AbbVie, Inc. ($20.31) |
All Payment Transactions
348 individual payment records from CMS Open Payments — Page 1 of 14
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/04/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $19.56 | General |
| Category: LIVER DISEASE | ||||||
| 11/19/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $25.40 | General |
| Category: LIVER DISEASE | ||||||
| 11/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $18.57 | General |
| Category: VIROLOGY | ||||||
| 10/23/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $21.51 | General |
| Category: LIVER DISEASE | ||||||
| 10/07/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 10/04/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $25.78 | General |
| Category: VIROLOGY | ||||||
| 09/24/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | TRULANCE (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Gastroenterology | ||||||
| 09/19/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $44.30 | General |
| Category: VIROLOGY | ||||||
| 09/12/2024 | Madrigal Pharmaceuticals | RESMETIROM (Drug) | Food and Beverage | In-kind items and services | $13.31 | General |
| Category: LIVER DISEASE | ||||||
| 08/27/2024 | IRONWOOD PHARMACEUTICALS, INC | Linzess (Drug) | Food and Beverage | Cash or cash equivalent | $17.08 | General |
| Category: GI | ||||||
| 08/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.43 | General |
| Category: IMMUNOLOGY | ||||||
| 08/21/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.57 | General |
| Category: VIROLOGY | ||||||
| 08/08/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $17.95 | General |
| 08/01/2024 | ABBVIE INC. | CREON (Drug) | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.66 | General |
| Category: Gastroenterology | ||||||
| 07/17/2024 | Ferring Pharmaceuticals Inc. | REBYOTA (Biological) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $24.61 | General |
| Category: IMMUNOLOGY | ||||||
| 07/13/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: General - Biliary Devices_ENDO | ||||||
| 07/11/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $26.28 | General |
| Category: VIROLOGY | ||||||
| 06/27/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: GASTROENTEROLOGY | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.83 | General |
| Category: Gastroenterology | ||||||
| 06/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $21.78 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 120 | 123 | $43,897 | $11,957 |
| 2022 | 8 | 168 | 174 | $64,348 | $18,052 |
| 2021 | 7 | 164 | 177 | $58,493 | $17,615 |
| 2020 | 6 | 140 | 158 | $45,737 | $14,120 |
Total Patients
592
Total Services
632
Medicare Billing
$61,745
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 22 | 22 | $7,040 | $2,408 | 34.2% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 14 | 15 | $12,105 | $2,248 | 18.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 20 | 20 | $5,360 | $1,935 | 36.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 19 | $3,914 | $1,934 | 49.4% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 18 | 18 | $9,576 | $1,418 | 14.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 16 | 16 | $3,328 | $1,356 | 40.7% |
| 99221 | Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | Facility | 2023 | 13 | 13 | $2,574 | $659.45 | 25.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 27 | 27 | $8,640 | $3,176 | 36.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 27 | 30 | $6,180 | $2,833 | 45.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 15 | 17 | $6,681 | $2,625 | 39.3% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 31 | 31 | $16,492 | $2,544 | 15.4% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $12,105 | $2,453 | 20.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 16 | 16 | $4,288 | $1,620 | 37.8% |
| 43235 | Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2022 | 15 | 15 | $6,765 | $1,486 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 22 | 23 | $3,197 | $1,315 | 41.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 27 | 27 | $8,640 | $3,467 | 40.1% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2021 | 30 | 31 | $16,492 | $3,145 | 19.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 27 | 30 | $6,180 | $3,070 | 49.7% |
| 45380 | Biopsy of the large bowel using an endoscope (colonoscopy) | Facility | 2021 | 19 | 19 | $15,333 | $2,708 | 17.7% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 15 | 15 | $5,895 | $2,366 | 40.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 29 | 36 | $3,312 | $1,571 | 47.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 17 | 19 | $2,641 | $1,290 | 48.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 37 | 37 | $11,840 | $4,492 | 37.9% |
| 43239 | Biopsy of the esophagus, stomach, and/or upper small bowel using an endoscope | Facility | 2020 | 25 | 26 | $13,832 | $2,822 | 20.4% |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 2020 | 14 | 14 | $9,436 | $2,637 | 27.9% |
About Dr. Ryan Barrientos, MD
Dr. Ryan Barrientos, MD is a Gastroenterology healthcare provider based in Houston, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/13/2012. The National Provider Identifier (NPI) number assigned to this provider is 1982975405.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Barrientos, MD has received a total of $10,574 in payments from pharmaceutical and medical device companies, with $841.41 received in 2024. These payments were reported across 348 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($6,235).
As a Medicare-enrolled provider, Barrientos has provided services to 592 Medicare beneficiaries, totaling 632 services with total Medicare billing of $61,745. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Gastroenterology
- Location Houston, TX
- Active Since 01/13/2012
- Last Updated 07/21/2022
- Taxonomy Code 207RG0100X
- Entity Type Individual
- NPI Number 1982975405
Products in Payments
- Talicia (Drug) $3,372
- TALICIA (Drug) $1,320
- RINVOQ (Biological) $424.35
- Humira (Biological) $412.18
- HUMIRA (Biological) $357.31
- MAVYRET (Drug) $267.92
- ZEPOSIA (Drug) $262.27
- LINZESS (Drug) $214.75
- Aemcolo (Drug) $204.91
- XIFAXAN (Drug) $191.50
- Mavyret (Drug) $156.53
- Sucraid (Drug) $154.32
- ZENPEP (Drug) $129.06
- Trulance (Drug) $126.89
- ENTYVIO (Biological) $122.75
- Movantik (Drug) $113.24
- TRULANCE (Drug) $107.21
- STELARA (Biological) $107.13
- CREON (Drug) $98.43
- GIMOTI (Drug) $96.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in Houston
Dr. Bincy Abraham, Md, MD
Gastroenterology — Payments: $1.9M
Gastroenterology $1.9M
Dr. Isaac Raijman, Md, MD
Gastroenterology — Payments: $1.6M
Gastroenterology $1.6M
Dr. Brooks Cash, Md, MD
Gastroenterology — Payments: $1.3M
Gastroenterology $1.3M
Dr. Mazen Noureddin, M.d, M.D
Gastroenterology — Payments: $786,099
Gastroenterology $786,099
Dr. Jason Hou, M.d, M.D
Gastroenterology — Payments: $372,514
Gastroenterology $372,514
Kalpesh Patel, Md, MD
Gastroenterology — Payments: $313,187
Gastroenterology $313,187